SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001019687-04-002359
Filing Date
2004-10-29
Accepted
2004-10-29 16:18:02
Documents
1
Period of Report
2004-10-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2848
  Complete submission text file 0001019687-04-002359.txt   4821
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Issuer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 14272 FRANKLIN AVENUE, #100 TUSTIN CA 92780
Business Address 714-508-6047
Waltz Thomas A (Reporting) CIK: 0001307421 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-17085 | Film No.: 041106679